Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Clinical Laboratories of Hawaii, LLP, commonly referred to as CLH, is a leading provider of tissue-typing and cell processing services headquartered in the United States. Established in 1995, CLH has built a strong reputation across Hawaii and the Pacific region, specialising in immunogenetics and transplantation diagnostics.
The laboratory offers a range of core services, including HLA typing, crossmatching, and cellular therapy processing, distinguished by their commitment to accuracy and rapid turnaround times. With state-of-the-art technology and a team of experienced professionals, CLH ensures high-quality results that support patient care and transplant success.
Recognised for its excellence in the field, Clinical Laboratories of Hawaii has positioned itself as a trusted partner for healthcare providers, contributing significantly to advancements in transplant medicine and patient outcomes.
No reported emissions data is available for Clinical Laboratories of Hawaii, LLP, Tissue-Typing and Cell Processing Lab yet.
Clinical Laboratories of Hawaii, LLP, Tissue-Typing and Cell Processing Lab currently does not have specific carbon emissions data available for the most recent year. As a merged entity, it inherits its climate commitments and emissions data from its parent organisation, Eurofins Scientific SE, at cascade level 4.
While no absolute emissions figures are provided, Eurofins Scientific SE has established various climate initiatives, including Science Based Targets (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Clinical Laboratories of Hawaii are not detailed in the available information.
The organisation's commitment to sustainability aligns with industry standards, reflecting a broader trend among clinical laboratories to address climate change and reduce their carbon footprint. As they continue to integrate these initiatives, further details on their specific emissions and reduction strategies may emerge in the future.
No climate goals have been disclosed for Clinical Laboratories of Hawaii, LLP, Tissue-Typing and Cell Processing Lab yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Clinical Laboratories of Hawaii, LLP, Tissue-Typing and Cell Processing Lab yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more